Literature DB >> 1965657

Regulation of sympathetic nerve activity in mild human hypertension.

A L Mark1.   

Abstract

There is substantial evidence for increased sympathetic nerve activity in young, mildly hypertensive humans. This evidence has been derived mainly from measurements of plasma catecholamines and from responses to adrenergic antagonists and agonists in normotensive and mildly hypertensive subjects. In addition, in recent studies direct measurements of sympathetic nerve activity to the muscle circulation have been obtained by microneurography. These data also indicate that sympathetic nerve activity is increased in young, mildly hypertensive humans. The present paper reviews this work with microneurographic measurements and highlights several concepts. (1) The increases in sympathetic nerve activity to the muscle in mild hypertension are not a result of impairment in the inhibitory influence of arterial baroreceptors; presumably, they reflect a heightened central nervous system sympathetic drive. (2) In the supine position the inhibitory influence of cardiopulmonary baroreceptors on sympathetic nerve activity is increased in mild hypertension. This increase in cardiopulmonary baroreflex control buffers the heightened sympathetic neural drive in mildly hypertensive subjects in the supine position, but withdrawal of this increase during orthostatic stress produces exaggerated reflex sympathetic vasoconstrictor responses to orthostasis in mildly hypertensive subjects. (3) Arterial chemoreceptor reflexes are increased in mildly hypertensive subjects and lead to exaggerated increases in sympathetic nerve activity during hypoxia. (4) There is increasing evidence that two humoral agents, epinephrine and insulin, exert excitatory effects on sympathetic neural outflow, which may contribute to the increased sympathetic activity and arterial pressure in human hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965657

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  6 in total

Review 1.  Centrally acting antihypertensive drugs: re-emergence of sympathetic inhibition in the treatment of hypertension.

Authors:  C R Benedict
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

2.  Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

Authors:  G Lembo; G Iaccarino; C Vecchione; E Barbato; R Izzo; D Fontana; B Trimarco
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Na+/Ca2+ exchanger overexpression in smooth muscle augments cytosolic Ca2+ in femoral arteries of living mice.

Authors:  Jin Zhang; Youhua Wang; Ling Chen; W Gil Wier; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-21       Impact factor: 4.733

4.  Is adrenaline released by sympathetic nerves in man?

Authors:  M Esler; G Eisenhofer; J Chin; G Jennings; I Meredith; H Cox; G Lambert; J Thompson; A Dart
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

5.  Weight reduction lowers blood pressure independently of salt restriction.

Authors:  G De Simone; M Mancini; G Mainenti; S Turco; L A Ferrara
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

Review 6.  Glia, sympathetic activity and cardiovascular disease.

Authors:  Nephtali Marina; Anja G Teschemacher; Sergey Kasparov; Alexander V Gourine
Journal:  Exp Physiol       Date:  2016-04-09       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.